Skip to main content

Market Overview

Progenics Pharmaceuticals Inc. (NASDAQ: )

0.00 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2020
Pre-Market
EPS:
REV:
-0.22
4.281M
-0.22
7.9M
-0.19
6.248M
13.64%
-20.91%
Q4 2019
Pre-Market
EPS:
REV:
-0.17
3.238M

-0.13
15.126M

Q3 2019
Pre-Market
EPS:
REV:
-0.01
5.317M

-0.22
5.613M

Q2 2019
Pre-Market
EPS:
REV:
-0.20
3.878M
-0.19
6.66M
-0.23
9.966M
-21.05%
49.64%
Q1 2019
Pre-Market
EPS:
REV:
-0.19
3.189M
-0.19
4.15M
-0.22
4.281M
-15.79%
3.16%
Q4 2018
Pre-Market
EPS:
REV:
-0.20
3.889M
-0.11
-0.17
3.238M
54.55%
Q3 2018
Pre-Market
EPS:
REV:
-0.22
2.697M
-0.18
4.12M
-0.01
5.317M
-94.44%
29.05%
Q2 2018
After-Hours
EPS:
REV:
-0.24
2.765M

-0.20
3.878M

Q1 2018
Pre-Market
EPS:
REV:
-0.23
2.347M
-0.21
4.35M
-0.19
3.189M
-9.52%
-26.69%
Q4 2017
Pre-Market
EPS:
REV:
-0.10
4.652M
-0.23
3.2M
-0.20
3.889M
-13.04%
21.53%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!